Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 34% ± 10% | |
peripheral blood | 15 studies | 29% ± 13% | |
intestine | 11 studies | 33% ± 12% | |
kidney | 8 studies | 28% ± 13% | |
brain | 8 studies | 25% ± 8% | |
eye | 7 studies | 43% ± 19% | |
liver | 6 studies | 31% ± 16% | |
pancreas | 5 studies | 53% ± 20% | |
bone marrow | 5 studies | 32% ± 16% | |
uterus | 5 studies | 48% ± 10% | |
lymph node | 5 studies | 26% ± 8% | |
placenta | 4 studies | 34% ± 9% | |
prostate | 4 studies | 37% ± 12% | |
breast | 4 studies | 48% ± 12% | |
adipose | 3 studies | 20% ± 4% | |
adrenal gland | 3 studies | 26% ± 3% | |
esophagus | 3 studies | 47% ± 18% | |
thymus | 3 studies | 47% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 32565.07 | 1445 / 1445 | 100% | 233.54 | 183 / 183 |
ovary | 100% | 20852.14 | 180 / 180 | 100% | 221.64 | 430 / 430 |
pancreas | 100% | 21425.64 | 328 / 328 | 100% | 320.39 | 178 / 178 |
prostate | 100% | 30390.40 | 245 / 245 | 100% | 444.13 | 502 / 502 |
skin | 100% | 25754.89 | 1809 / 1809 | 100% | 358.66 | 472 / 472 |
thymus | 100% | 22022.73 | 653 / 653 | 100% | 288.51 | 605 / 605 |
uterus | 100% | 26263.61 | 170 / 170 | 100% | 373.09 | 459 / 459 |
lung | 100% | 28934.85 | 578 / 578 | 100% | 325.41 | 1153 / 1155 |
intestine | 100% | 38945.14 | 966 / 966 | 100% | 319.97 | 526 / 527 |
liver | 100% | 16159.33 | 226 / 226 | 100% | 269.63 | 405 / 406 |
stomach | 100% | 28639.23 | 359 / 359 | 100% | 278.76 | 285 / 286 |
bladder | 100% | 37422.14 | 21 / 21 | 100% | 327.38 | 502 / 504 |
adrenal gland | 100% | 24084.91 | 258 / 258 | 100% | 287.06 | 229 / 230 |
breast | 100% | 32098.15 | 459 / 459 | 99% | 344.79 | 1112 / 1118 |
kidney | 100% | 19592.47 | 89 / 89 | 99% | 251.42 | 895 / 901 |
brain | 98% | 12890.08 | 2595 / 2642 | 100% | 295.81 | 705 / 705 |
adipose | 100% | 36041.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 37107.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 388.21 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 333.06 | 29 / 29 |
muscle | 100% | 28155.71 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 22465.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 347.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 209.87 | 1 / 1 |
heart | 98% | 14789.18 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 12881.54 | 843 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_1990253 | Biological process | cellular response to leucine starvation |
GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0045667 | Biological process | regulation of osteoblast differentiation |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_1990737 | Biological process | response to manganese-induced endoplasmic reticulum stress |
GO_0034644 | Biological process | cellular response to UV |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0140468 | Biological process | HRI-mediated signaling |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0030182 | Biological process | neuron differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_2000120 | Biological process | positive regulation of sodium-dependent phosphate transport |
GO_0070169 | Biological process | positive regulation of biomineral tissue development |
GO_0036499 | Biological process | PERK-mediated unfolded protein response |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0043267 | Biological process | negative regulation of potassium ion transport |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0009636 | Biological process | response to toxic substance |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032057 | Biological process | negative regulation of translational initiation in response to stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_1905461 | Biological process | positive regulation of vascular associated smooth muscle cell apoptotic process |
GO_0070982 | Biological process | L-asparagine metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0031667 | Biological process | response to nutrient levels |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0006094 | Biological process | gluconeogenesis |
GO_0070309 | Biological process | lens fiber cell morphogenesis |
GO_0030282 | Biological process | bone mineralization |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_1990617 | Cellular component | CHOP-ATF4 complex |
GO_0043005 | Cellular component | neuron projection |
GO_0005634 | Cellular component | nucleus |
GO_1990589 | Cellular component | ATF4-CREB1 transcription factor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990037 | Cellular component | Lewy body core |
GO_1990590 | Cellular component | ATF1-ATF4 transcription factor complex |
GO_0034399 | Cellular component | nuclear periphery |
GO_0032590 | Cellular component | dendrite membrane |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0042802 | Molecular function | identical protein binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0008140 | Molecular function | cAMP response element binding protein binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0043522 | Molecular function | leucine zipper domain binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140296 | Molecular function | general transcription initiation factor binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0019901 | Molecular function | protein kinase binding |
Gene name | ATF4 |
Protein name | Cyclic AMP-dependent transcription factor ATF-4 (Activating transcription factor 4) Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (Tax-responsive enhancer element-binding protein 67) (TaxREB67) Cyclic AMP-dependent transcription factor ATF-4 Activating transcription factor 4 |
Synonyms | TXREB CREB2 |
Description | FUNCTION: Transcription factor that binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3') and displays two biological functions, as regulator of metabolic and redox processes under normal cellular conditions, and as master transcription factor during integrated stress response (ISR) . Binds to asymmetric CRE's as a heterodimer and to palindromic CRE's as a homodimer (By similarity). Core effector of the ISR, which is required for adaptation to various stress such as endoplasmic reticulum (ER) stress, amino acid starvation, mitochondrial stress or oxidative stress . During ISR, ATF4 translation is induced via an alternative ribosome translation re-initiation mechanism in response to EIF2S1/eIF-2-alpha phosphorylation, and stress-induced ATF4 acts as a master transcription factor of stress-responsive genes in order to promote cell recovery . Promotes the transcription of genes linked to amino acid sufficiency and resistance to oxidative stress to protect cells against metabolic consequences of ER oxidation (By similarity). Activates the transcription of NLRP1, possibly in concert with other factors in response to ER stress . Activates the transcription of asparagine synthetase (ASNS) in response to amino acid deprivation or ER stress . However, when associated with DDIT3/CHOP, the transcriptional activation of the ASNS gene is inhibited in response to amino acid deprivation . Together with DDIT3/CHOP, mediates programmed cell death by promoting the expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the terminal unfolded protein response (terminal UPR), a cellular response that elicits programmed cell death when ER stress is prolonged and unresolved (By similarity). Together with DDIT3/CHOP, activates the transcription of the IRS-regulator TRIB3 and promotes ER stress-induced neuronal cell death by regulating the expression of BBC3/PUMA in response to ER stress . May cooperate with the UPR transcriptional regulator QRICH1 to regulate ER protein homeostasis which is critical for cell viability in response to ER stress . In the absence of stress, ATF4 translation is at low levels and it is required for normal metabolic processes such as embryonic lens formation, fetal liver hematopoiesis, bone development and synaptic plasticity (By similarity). Acts as a regulator of osteoblast differentiation in response to phosphorylation by RPS6KA3/RSK2: phosphorylation in osteoblasts enhances transactivation activity and promotes expression of osteoblast-specific genes and post-transcriptionally regulates the synthesis of Type I collagen, the main constituent of the bone matrix . Cooperates with FOXO1 in osteoblasts to regulate glucose homeostasis through suppression of beta-cell production and decrease in insulin production (By similarity). Activates transcription of SIRT4 (By similarity). Regulates the circadian expression of the core clock component PER2 and the serotonin transporter SLC6A4 (By similarity). Binds in a circadian time-dependent manner to the cAMP response elements (CRE) in the SLC6A4 and PER2 promoters and periodically activates the transcription of these genes (By similarity). Mainly acts as a transcriptional activator in cellular stress adaptation, but it can also act as a transcriptional repressor: acts as a regulator of synaptic plasticity by repressing transcription, thereby inhibiting induction and maintenance of long-term memory (By similarity). Regulates synaptic functions via interaction with DISC1 in neurons, which inhibits ATF4 transcription factor activity by disrupting ATF4 dimerization and DNA-binding . .; FUNCTION: (Microbial infection) Binds to a Tax-responsive enhancer element in the long terminal repeat of HTLV-I. . |
Accessions | ENST00000680748.1 ENST00000674835 ENST00000676346 ENST00000674920.3 A0A6Q8PGY1 ENST00000680446.1 A0A6Q8PFH6 ENST00000676346.2 ENST00000404241.6 P18848 A0A6Q8PG17 ENST00000674835.2 ENST00000396680.3 Q6ICP0 ENST00000674568.2 ENST00000675582.2 ENST00000674568 ENST00000679776.1 ENST00000337304.2 B4DJD4 A0A6Q8PHB3 A0A7P0Z4J5 |